About this document
Levosimendan by Daniela Landinez is a document available to read on EtoBox.
Levosimendan, an inotropic and vasodilating drug, showed limited success in improving pulmonary capillary wedge pressure and 6-minute walk test distance in patients with pulmonary hypertension and preserved ejection fraction heart failure (PH-HFpEF) in a phase-2 study. Although the primary endpoint was not met, researchers believe the drug warrants further investigation in larger trials. The study highlights the challenges of applying these findings to the heterogeneous real-world population of HFpEF patien
- Author
- Daniela Landinez
- Language
- EN